Publikationen
von Fritsch L, Duhn J, Abdalla TSA, Honselmann KC, Bolm L, Braun R, Kist M, Lapshyn H, Zeissig SR, Klinkhammer-Schalke M, Kleihues van Tol K, Litkevych S, Reinwald F, Sackmann A, Franke B, Holleczek B, Krauß A, Deichmann S, Keck T, Wellner UF.
An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from the German Cancer Registry Group
Eur J Surg Oncol. 2025 Feb 14;51(6):109693. doi: 10.1016/j.ejso.2025.109693. Online ahead of print.
Duhn J, von Fritsch L, Bolm L, Braun R, Honselmann K, Litkevych S, Kist M, Deichmann S, Tol KK, Franke B, Reinwald F, Sackmann A, Holleczek B, Krauß A, Klinkhammer-Schalke M, Zeissig SR, Keck T, Wellner UF, Abdalla TSA
Perioperative and oncologic outcomes after total pancreatectomy and pancreatoduodenectomy for pancreatic head adenocarcinoma - A propensity score–matched analysis from the German Cancer Registry Group
Maria Elena Lacruz, Saskia Thies, Andrea Schmidt-Pokrzywniak, Ian Wittenberg, Tobias Engler, Fabian Reinwald, Monika Klinkhammer-Schalke, Sylke Ruth Zeissig, Bianca Franke, Kerstin Weitmann, Atanas Ignatov
Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer
Thomas Papathemelis, Olaf Ortmann, Cynthia Kohl, Petra Neuser, Kees Kleihues-van Tol, Monika Klinkhammer-Schalke, Peter Ugocsai, Christina Barbara Walter, Miriam Rottmann, Catherine Real, Christina Justenhoven, Gabriele Robers, Constanze Schneider, Michael Gerken, Andrea Sackmann & Soo-Zin Kim-Wanner
Treatment of endometrial cancer from 2000 to 2020 in Germany: a retrospective population based cohort study
J Cancer Res Clin Oncol 150, 279 (2024). https://doi.org/10.1007/s00432-024-05772-9
Abdalla TSA, Duhn J, Klinkhammer-Schalke M, Zeissig SR, Kleihues-van Tol K, Honselmann KC, Braun R, Kist M, Bolm L, von Fritsch L, Lapshyn H, Litkevych S, Hummel R, Zemskov S, Wellner UF, Keck T, Deichmann S.
Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic Ductal Adenocarcinoma: An Analysis from the German Cancer Registry Group of the Society of German Tumor Centers
Cancers (Basel). 2024 May 26;16(11):2016. doi: 10.3390/cancers16112016.
Petruch N, Servin Rojas M, Lillemoe KD, Castillo CF, Braun R, Honselmann KC, Lapshyn H, Deichmann S, Abdalla TSA, Hummel R, Klinkhammer-Schalke M, Tol KK, Zeissig SR, Keck T, Wellner UF, Qadan M, Bolm L.
The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries
Surgery. 2024 Apr;175(4):1120-1127. doi: 10.1016/j.surg.2023.11.004. Epub 2023 Dec 13.
Abdalla TSA, Bolm L, Klinkhammer-Schalke M, Zeissig SR, Kleihues van Tol K, Bronsert P, Litkevych S, Honselmann KC, Braun R, Gebauer J, Hummel R, Keck T, Wellner UF, Deichmann S.
When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group
Cancers (Basel). 2024 Jan 19;16(2):440. doi: 10.3390/cancers16020440.
Abdalla TSA, Klinkhammer-Schalke M, Zeissig SR, Tol KK, Honselmann KC, Braun R, Bolm L, Lapshyn H, Litkevych S, Zemskov S, Begum N, Kulemann B, Hummel R, Wellner UF, Keck T, Deichmann S.
Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers
Abdalla TSA, Pieper L, Kist M, Thomaschewski M, Klinkhammer-Schalke M, Zeissig SR, Tol KK, Wellner UF, Keck T, Hummel R.
Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group
Kist M, Thomaschewski M, Keck Y, Abdalla TSA, Zeissig SR, Kleihues-van Tol K, Wellner UF, Keck T, Hoeppner J, Hummel R.
Specifics of Young Gastric Cancer Patients: A Population-Based Analysis of 46,110 Patients with Gastric Cancer from the German Clinical Cancer Registry Group
Cancers (Basel). 2022 Nov 30;14(23):5927. doi: 10.3390/cancers14235927.
Braun R, Klinkhammer-Schalke M, Zeissig SR, Kleihus van Tol K, Bolm L, Honselmann KC, Petrova E, Lapshyn H, Deichmann S, Abdalla TSA, Heckelmann B, Bronsert P, Zemskov S, Hummel R, Keck T, Wellner UF.
Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group.
Deichmann S, Dworschak O, Kulemann B, Höppner J, Bolm L, Klinkhammer-Schalke M, Zeissig SR, Kleihus van Tol K, Braun R, Lapshyn H, Keck T, Wellner UF, Honselmann KC.
Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective
Zentralbl Chir. 2022 Apr;147(2):147-154. doi: 10.1055/a-1768-1012. Epub 2022 Apr 4.
Bolm L, Zemskov S, Zeller M, Baba T, Roldan J, Harrison JM, Petruch N, Sato H, Petrova E, Lapshyn H, Braun R, Honselmann KC, Hummel R, Dronov O, Kirichenko AV, Klinkhammer-Schalke M, Kleihues-van Tol K, Zeissig SR, Rades D, Keck T, Fernandez-Del Castillo C, Wellner UF, Wegner RE.
Concepts an Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database and the German Cancer Registry Group of Society of German Tumor Centers
Cancers (Basel). 2022 Feb 9;14(4):868. doi: 10.3390/cancers14040868.
Petrova E, Wellner J, Nording AK, Braun R, Honselmann KC, Bolm L, Hummel R, Klinkhammer-Schalke M, Zeissig SR, Kleihues van Tol K, Timme-Bronsert S, Bronsert P, Zemskov S, Keck T, Wellner UF.
Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group
Cancers (Basel). 2021 Dec 4;13(23):6121. doi: 10.3390/cancers13236121.
Draeger T, Völkel V, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, Fürst A.
Laparoscopic and open resection of rectal cancer-is age an effect modifier for short- and long-term survival?
Völkel V, Draeger T, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, Fürst A. (2019)
Surgical treatment of rectal cancer patients aged 80 years and older-a German nationwide analysis comparing short- and long-term survival after laparoscopic and open tumor resection.
Eur J Surg Oncol. 2019 May 9. pii: S0748-7983(19)30443-3. doi:10.1016/j.ejso.2019.05.005. [Epub ahead of print] PMID: 31092363
Schnitzbauer V, Gerken M, Benz S, Völkel V, Draeger T, Fürst A, Klinkhammer-Schalke M.
Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort.
Surg Endosc. 2020 Mar;34(3):1132-1141. doi: 10.1007/s00464-019-06861-4. Epub 2019 May 30. PMID: 31147825
Teufel A, Gerken M, Fürst A, Ebert M, Hohenthanner I, Klinkhammer-Schalke M.
Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer.
Eur J Cancer. 2020 Aug 7;137:148-160. doi: 10.1016/j.ejca.2020.06.036. Online ahead of print. PMID: 32777714
Schmuck R, Gerken M, Teegen EM, Krebs I, Klinkhammer-Schalke M, Aigner F, Pratschke J, Rau B, Benz S.
Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients.
Langenbecks Arch Surg. 2020 Jan 31. doi: 10.1007/s00423-019-01850-6. [Epub ahead of print] PMID:32002628